Genetic Engineering & Biotechnology News

Genetic Engineering & Biotechnology News The world's most widely read biotechnology publication. Also follow us on Twitter .

GEN's print coverage, which can easily be accessed online, includes industry-standard tutorials and technical articles in bioprocessing, assays, and drug discovery; feature articles on emerging technologies; product roundups and regional biofocus articles on biotech hotbeds; as well as reports from key scientific and industry meetings. Our acclaimed columns include Wall Street BioBeat, Point of Vi

ew, Corporate Profile, Biomarket Trends, Legal Affairs, and Best of the Web. Other regular, informative content includes New Product listings and the Calendar of Events column for bioscience and bioindustry meetings. GEN's print edition also features the following news columns: Clinical Trials Update, Genomics & Proteomics, Discovery and Development Briefs, Bioprocessing Highlights, Molecular Diagnostics, Inside Industry, Product & Service Deals, and People in the News. GEN online has additional editorial coverage including GEN News Highlights, which covers the most important stories in the life sciences on a daily basis, helping you stay current. The Analysis & Insight section is an online exclusive column that slices and dices the latest news and trends that are shaping the industry. BLOGbiotech is another online exclusive offering that discusses controversial, hot topics that are affecting biotech. GEN online also provides you with illustrative and instructional Webinars and Application Notes on technology developments. You can also listen to thought-provoking Podcasts, hosted by GEN's editor in chief, John Sterling, and take part in our Polls, which are pick based on high-profile news events.

Particle Measuring Systems Opens New Manufacturing and Contamination Control Innovation HubThe completed PMS facility sp...
08/20/2025

Particle Measuring Systems Opens New Manufacturing and Contamination Control Innovation Hub

The completed PMS facility spans over 80,000-sq-ft with an additional 20,000-sq-ft reserved for future growth and expansion.

The completed PMS facility spans over 80,000-sq-ft with an additional 20,000-sq-ft reserved for future growth and expansion.

A Noble Pursuit: Genetics and Drug Discovery RevisitedGenetic technologies are rapidly progressing, but the incentives f...
08/20/2025

A Noble Pursuit: Genetics and Drug Discovery Revisited

Genetic technologies are rapidly progressing, but the incentives for applying them are unclear. Don't miss our August issue Point of View by British biotech veteran entrepreneur Tim Harris, PhD.

Genetic technologies are rapidly progressing, but the incentives for applying them are unclear.

NEW GEN Live! How Organoids Are Revolutionizing Neuroscience ResearchBroadcast Date: Wednesday, August 27, 2025Time: 09:...
08/20/2025

NEW GEN Live! How Organoids Are Revolutionizing Neuroscience Research

Broadcast Date: Wednesday, August 27, 2025
Time: 09:00 PDT, 12:00 EDT, 16:00 GMT

The organoid field has come a long way in a relatively short amount of time. The role of organoids in the field of neuroscience has been particularly exciting—accelerating new discoveries and uncovering layers of biology that were previously inaccessible through traditional cell culture or animal models. Neural organoids are opening new frontiers in understanding human brain development, disease modeling of neurological disorders including—but not limited to—psychiatric disorders, and therapeutic development. While challenges remain, many believe organoids are entering their heyday, poised to transform both basic research and translational medicine.

On this episode of GEN Live, we’ll discuss how organoids are advancing research with a particular focus on neural organoids. We’ll discuss where the field stands today, recent advances, and the challenges that need to be addressed. Experts join us to explore how organoids are aiding the development of new therapeutics and paving the way toward the long-term goals of precision medicine and cell and tissue-replacement therapies.

Register now to join us for this free webinar sponsored by R&D Systems, a Bio-Techne brand: https://hubs.li/Q03DzH210

Harnessing Data and AI to Revolutionize Bioprocessing Beyond DigitalBill Levine, VP and commercial director of GEN, repo...
08/20/2025

Harnessing Data and AI to Revolutionize Bioprocessing Beyond Digital

Bill Levine, VP and commercial director of GEN, reports from a session at today's Bioprocessing Summit in Boston where Sanofi's Cenk Undey, PhD, challenged the audience to look “beyond digital.”

GEN reports from the Bioprocessing Summit where Sanofi's Cenk Undey, PhD, challenged the audience to look “beyond digital.”

We’re live at the   in Boston (Aug 18–21)!From Upstream and Downstream Innovations to AI, Digitization, Analytical Quali...
08/20/2025

We’re live at the in Boston (Aug 18–21)!

From Upstream and Downstream Innovations to AI, Digitization, Analytical Quality, RNA, Cell/Gene Therapy, and Formulation & Stability — the exhibit hall, networking tables, and poster sessions are alive with insight and energy.

If you're attending too, let’s connect — we’d love to share how Genetic Engineering & Biotechnology News can help keep your brand top of mind.

Thanks to Cambridge Healthtech Institute for hosting this event!

Ischemia Drives Breast Cancer Growth in Mice by Weakening ImmunityNYU Langone Health researchers suggest targeting infla...
08/20/2025

Ischemia Drives Breast Cancer Growth in Mice by Weakening Immunity

NYU Langone Health researchers suggest targeting inflammation may offer a promising therapeutic strategy at the intersection of cancer and cardiovascular disease.

NYU Grossman School of Medicine

Researchers suggest targeting inflammation may offer a promising therapeutic strategy at the intersection of cancer and cardiovascular disease.

Industry Partnerships with Iowa State University to Support New Scale-Up FacilityBioMADE’s investment in Iowa is expecte...
08/20/2025

Industry Partnerships with Iowa State University to Support New Scale-Up Facility

BioMADE’s investment in Iowa is expected to provide access to the technology infrastructure required to determine if a product is commercially viable. BioMADE is a U.S. Department of Defense (DoD) Manufacturing Innovation Institute,

BioMADE’s investment in Iowa is expected to provide access to the technology infrastructure required to determine if a product is commercially viable.

Made Scientific Opens Its New GMP Manufacturing Facility and HQ in Princeton, NJThe company's new facility opening marks...
08/19/2025

Made Scientific Opens Its New GMP Manufacturing Facility and HQ in Princeton, NJ

The company's new facility opening marks the completion of a $12 million initial investment in facility upgrades and equipment.

Princeton, NJ Government

Made Scientific's new facility opening marks the completion of a $12 million initial investment in facility upgrades and equipment.

Brain Abnormalities in Children Tied to Prenatal Pesticide ExposureResearchers at Columbia University, Children's Hospit...
08/19/2025

Brain Abnormalities in Children Tied to Prenatal Pesticide Exposure

Researchers at Columbia University, Children's Hospital Los Angeles, and Keck School of Medicine of USC say minimizing prenatal and early life exposure to CPF and other pesticides is likely important for optimal childhood brain development.

Researchers say minimizing prenatal and early life exposure to CPF and other pesticides is likely important for optimal childhood brain development.

VantAI, Halda Therapeutics Launch $1B+ Proximity-Based Therapy CollaborationVantAI's AI platform will accelerate program...
08/19/2025

VantAI, Halda Therapeutics Launch $1B+ Proximity-Based Therapy Collaboration

VantAI's AI platform will accelerate programmable protein interaction therapies across Halda's cancer and immunology indications.

ArtificialIntelligence

VantAI's AI platform will accelerate programmable protein interaction therapies across Halda's cancer and immunology indications.

Top 10 U.S. Biopharma Clusters 2025Regions face reduced federal research funding and shrinking venture capital for start...
08/19/2025

Top 10 U.S. Biopharma Clusters 2025

Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent. Alex Philippidis' list is designed to show which regions are most competitive in attracting life sciences leaders, companies, and institutions.

Regions face reduced federal research funding and shrinking venture capital for startups, though rankings stay consistent.

Address

140 Huguenot St
New Rochelle, NY
10801

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Website

http://www.linkedin.com/company/genetic-engineering-&-biotechnology-news, http://www.twitter

Alerts

Be the first to know and let us send you an email when Genetic Engineering & Biotechnology News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Genetic Engineering & Biotechnology News:

Share

Category